Last reviewed · How we verify
Phase 1: Etanercept
Phase 1: Etanercept is a Biologic drug developed by Pfizer. It is currently FDA-approved. Also known as: Enbrel.
Etanercept, marketed by Pfizer, is a well-established drug in the therapeutic landscape with a key composition patent expiring in 2028. Its primary strength lies in its robust market presence and revenue generation. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Phase 1: Etanercept |
|---|---|
| Also known as | Enbrel |
| Sponsor | Pfizer |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (PHASE3)
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants (PHASE3)
- Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease (PHASE2)
- NATIENS: Optimal Management and Mechanisms of SJS/TEN (PHASE3)
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC (PHASE1)
- Anti-inflammatory Therapy to Improve Outcomes After TPIAT (PHASE4)
- A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants (PHASE1)
- TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phase 1: Etanercept CI brief — competitive landscape report
- Phase 1: Etanercept updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Phase 1: Etanercept
What is Phase 1: Etanercept?
Who makes Phase 1: Etanercept?
Is Phase 1: Etanercept also known as anything else?
What development phase is Phase 1: Etanercept in?
Related
- Manufacturer: Pfizer — full pipeline
- Also known as: Enbrel
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing